Flemish and Dutch Mutations in Amyloid &bgr; Precursor Protein Have Different Effects on Amyloid &bgr; Secretion

By de Jonghe C.   Zehr C.   Yager D.   Prada C-M.   Younkin S.   Hendriks L.   van Broeckhoven C.   Eckman C.B.  

Neurobiology of Disease, Vol. 5, Iss. 4, 1998-10 ,pp. : 281-286

Academic Press

Access to resources Recommend Favorite

Receptor-Mediated Transport of Human Amyloid &bgr;-Protein 1–40 and 1–42 at the Blood–Brain Barrier

By Poduslo J.F.   Curran G.L.   Sanyal B.   Selkoe D.J.  

Neurobiology of Disease, Vol. 6, Iss. 3, 1999-06 ,pp. : 190-199

Academic Press

Access to resources Recommend Favorite

Fluoxetine Improves Behavioral Performance by Suppressing the Production of Soluble &bgr;-Amyloid in APP/PS1 Mice

By  

Current Alzheimer Research, Vol. 11, Iss. 7, 2014-09 ,pp. : 672-680

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Long-Term Treatment with Metrifonate, a Cholinesterase Inhibitor, on Cholinergic Activity, Amyloid Pathology, and Cognitive Function in APP and PS1 Doubly Transgenic Mice

By Liu L.   Ikonen S.   Heikkinen T.   Tapiola T.   van Groen T.   Tanila H.  

Experimental Neurology, Vol. 173, Iss. 2, 2002-02 ,pp. : 196-204

Elsevier

Access to resources Recommend Favorite

Fimbria–Fornix Lesion Does Not Affect APP Levels and Amyloid Deposition in the Hippocampus of APP+PS1 Double Transgenic Mice

By Liu L.   Ikonen S.   Tapiola T.   Tanila H.   van Groen T.  

Experimental Neurology, Vol. 177, Iss. 2, 2002-10 ,pp. : 565-574

Academic Press

Access to resources Recommend Favorite